The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer (Q35054821)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael C. Stauder

object named as

Michael C Stauder

3

0 references

Wendy A Woodward

object named as

Wendy A Woodward

13

0 references

10

object named as

Mark F Munsell

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Karen E Hoffman

2

object named as

Karen E Hoffman

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

object named as

Eric A Strom

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Simona F Shaitelman

4

object named as

Simona F Shaitelman

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

6

object named as

Welela Tereffe

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Nikhil G Thaker

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Benjamin D Smith

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

George H Perkins

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lei Huo

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lajos Pusztai

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Thomas A Buchholz

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

30 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

copyright license

Creative Commons Attribution 4.0 International

30 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Breast cancer subtypes and the risk of local and regional relapse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Predicting a local recurrence after breast-conserving therapy by gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Molecular and genetic markers in the local-regional management of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

8 July 2018

Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool.

1 reference

https://api.crossref.org/works/10.1186%2FS40064-015-0840-Y

21 January 2018

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project random

1 reference

https://api.crossref.org/works/10.1186%2FS40064-015-0840-Y

21 January 2018

Higher Ki67 expression is associates with unfavorable prognostic factors and shorter survival in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4318826

25 October 2018

Risk factors. Oncotype DX assay predicts local recurrence in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genomic prediction of locoregional recurrence after mastectomy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25674496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S40064-015-0840-Y

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35054821&oldid=2197198625"